Potomac Analytics' Logo

Broker-Dealers on SEC Form D for AEGIS CAPITAL CORP.

Form Ds provide information on individual, unregistered securities offerings.

Search by Recipient Name or Primary Issuer:

Filter by:

Sort by:

Displaying 51-60 out of 175 results
Recipient CRD Primary Issuer CIK Filing Date Form Type Total Offering Amount Total Amount Sold
AEGIS CAPITAL CORP.15007HYDROFARM HOLDINGS GROUP, INC.169529512/17/2019D$10,000,000$7,531,840
AEGIS CAPITAL CORP.15007GLOBEIMMUNE INC124510402/13/2014D$7,500,000$7,500,000
AEGIS CAPITAL CORP.15007Aegis Special Situations Fund LLC - Series Medtech IX194182108/30/2022D$10,000,000$7,185,000
AEGIS CAPITAL CORP.15007Crescent Moon Investors, LLC175992511/26/2018D$7,010,000$7,010,000
AEGIS CAPITAL CORP.15007Agritech Partners LLC - Series HB-1186694806/11/2021D$40,000,000$6,610,000
AEGIS CAPITAL CORP.15007Corbus Pharmaceuticals Holdings, Inc.159509704/23/2014D$13,000,000$6,310,000
AEGIS CAPITAL CORP.15007CleanTech Innovations, Inc.138221907/15/2010D$10,000,000$5,644,000
AEGIS CAPITAL CORP.15007DelMar Pharmaceuticals, Inc.149838205/10/2016DIndefinite$5,600,000
AEGIS CAPITAL CORP.15007Aegis Special Situations Fund LLC - Series Medtech VI189305111/10/2021D$12,000,000$5,595,000
AEGIS CAPITAL CORP.15007Aerami Therapeutics Holdings, Inc.165084012/16/2022D$20,000,000$5,380,000

175 Results

Display: